ITRM · Categories · Form 4
ITRM - SEC Form 4 insider transactions
Iterum Therapeutics plc (ITRM) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for ITRM
- SEC Form 4 filed by Chief Commercial Officer Coyne Christine4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Director Hunt Ronald4 - Iterum Therapeutics plc (0001659323) (Issuer)
- Director Dunne Michael W. converted options into 106,247 units of Ordinary Shares, increasing direct ownership by 93% to 220,001 units (SEC Form 4)4 - Iterum Therapeutics plc (0001659323) (Issuer)
- Chief Executive Officer Fishman Corey N. converted options into 82,613 units of Ordinary Shares, increasing direct ownership by 152% to 137,062 units (SEC Form 4)4 - Iterum Therapeutics plc (0001659323) (Issuer)
- Director Hunt Ronald converted options into 247,934 units of Ordinary Shares (SEC Form 4)4 - Iterum Therapeutics plc (0001659323) (Issuer)
- Puttagunta Sailaja was granted 8,333 units of Ordinary Shares and covered exercise/tax liability with 2,933 units of Ordinary Shares, increasing direct ownership by 109% to 10,369 units (SEC Form 4)4 - Iterum Therapeutics plc (0001659323) (Issuer)
- Hunt Ronald converted options into 5,479 units of Ordinary Shares, increasing direct ownership by 62% to 14,346 units (SEC Form 4)4 - Iterum Therapeutics plc (0001659323) (Issuer)
- Dunne Michael W. converted options into 3,487 units of Ordinary Shares, increasing direct ownership by 6% to 58,754 units (SEC Form 4)4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Hunt Ronald4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Dunne Michael W.4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Chin Mark4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Dunne Michael W.4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Hecht Beth4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Dunne Michael W. (Amendment)4/A - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Dunne Michael W.4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Matthews Judith M.4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Puttagunta Sailaja4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Hunt Ronald4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Fishman Corey N.4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4: Fishman Corey N. was granted 14,333 units of Ordinary Shares and covered exercise/tax liability with 5,683 units of Ordinary Shares, increasing direct ownership by 24% to 44,449 units (for withholding tax)4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4: Matthews Judith M. was granted 6,666 units of Ordinary Shares and covered exercise/tax liability with 2,883 units of Ordinary Shares, increasing direct ownership by 87% to 8,135 units (withholding tax)4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Dunne Michael W. (Amendment)4/A - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4: Hunt Ronald converted options into 1,197 units of Ordinary Shares, increasing direct ownership by 42% to 4,030 units4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4: Dunne Michael W. converted options into 761 units of Ordinary Shares, increasing direct ownership by 2% to 36,337 units4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Hunt Ronald4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Dunne Michael W.4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Ahrens Brenton Karl4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4: Puttagunta Sailaja was granted 8,334 units of Ordinary Shares and sold $4,442 worth of Ordinary Shares (3,365 units at $1.32) to cover withholding tax4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Ahrens Brenton Karl4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Hunt Ronald4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Dunne Michael W.4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4: Ahrens Brenton Karl sold $67,930 worth of Ordinary Shares (37,246 units at $1.82)4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4: Ahrens Brenton Karl sold $93,846 worth of Ordinary Shares (45,000 units at $2.09)4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4: Ahrens Brenton Karl sold $76,803 worth of Ordinary Shares (33,298 units at $2.31)4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4: Dunne Michael W. bought $22,200 worth of Ordinary Shares (10,000 units at $2.22), increasing direct ownership by 39% to 35,576 units4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Ahrens Brenton Karl4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Hunt Ronald4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Dunne Michael W.4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4: Dunne Michael W. converted options into 36,798 units of Ordinary Shares, increasing direct ownership by 11% to 383,647 units4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4: Chin Mark converted options into 36,798 units of Ordinary Shares4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4: Hunt Ronald converted options into 36,798 units of Ordinary Shares, increasing direct ownership by 645% to 42,501 units4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4: Hecht Beth converted options into 36,798 units of Ordinary Shares, increasing direct ownership by 460% to 44,805 units4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Hecht Beth4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Kelly David George4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Ahrens Brenton Karl4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Chin Mark4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Hunt Ronald4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Dunne Michael W.4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Hunt Ronald4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Ahrens Brenton Karl4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4: Dunne Michael W. converted options into 10,494 units of Ordinary Shares, increasing direct ownership by 3% to 346,849 units4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4: Hecht Beth converted options into 7,642 units of Ordinary Shares, increasing direct ownership by 2,094% to 8,007 units4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4: Matthews Judith M. sold $19,635 worth of Ordinary Shares (63,340 units at $0.31), decreasing direct ownership by 49% to 65,292 units (tax liability) (Amendment)4/A - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4: Matthews Judith M. was granted 100,000 units of Ordinary Shares and sold $17,910 worth of Ordinary Shares (47,132 units at $0.38), increasing direct ownership by 185% to 81,500 units (for withholding tax)4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4: Fishman Corey N. converted options into 215,000 units of Ordinary Shares, increasing direct ownership by 67% to 537,008 units4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Puttagunta Sailaja4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4: Dunne Michael W. was granted 80,000 units of Ordinary Shares, increasing direct ownership by 31% to 336,355 units4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Chin Mark4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by HUNT RONALD4 - Iterum Therapeutics plc (0001659323) (Issuer)
- SEC Form 4 filed by Ahrens Brenton Karl4 - Iterum Therapeutics plc (0001659323) (Issuer)